The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Bronchiectasis


High impact information on Bronchiectasis


Chemical compound and disease context of Bronchiectasis


Biological context of Bronchiectasis


Anatomical context of Bronchiectasis


Gene context of Bronchiectasis


Analytical, diagnostic and therapeutic context of Bronchiectasis


  1. Kartagener's syndrome. Woodring, J.H., Royer, J.M., McDonagh, D. JAMA (1982) [Pubmed]
  2. Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. Vandivier, R.W., Fadok, V.A., Hoffmann, P.R., Bratton, D.L., Penvari, C., Brown, K.K., Brain, J.D., Accurso, F.J., Henson, P.M. J. Clin. Invest. (2002) [Pubmed]
  3. Sweat chloride and delta F508 mutation in chronic bronchitis or bronchiectasis. Gervais, R., Lafitte, J.J., Dumur, V., Kesteloot, M., Lalau, G., Houdret, N., Roussel, P. Lancet (1993) [Pubmed]
  4. Type 2 nitric oxide synthase and protein nitration in chronic lung infection. Hopkins, N., Cadogan, E., Giles, S., Bannigan, J., McLoughlin, P. J. Pathol. (2003) [Pubmed]
  5. Comparison of exhaled and nasal nitric oxide and exhaled carbon monoxide levels in bronchiectatic patients with and without primary ciliary dyskinesia. Horváth, I., Loukides, S., Wodehouse, T., Csiszér, E., Cole, P.J., Kharitonov, S.A., Barnes, P.J. Thorax (2003) [Pubmed]
  6. Bronchiectasis in the immotile-cilia syndrome. Guerrant, J.L., Douty, T., Tegtmeyer, C., Jahrsdoerfer, R.A. N. Engl. J. Med. (1978) [Pubmed]
  7. Neutrophils from subjects with chronic obstructive lung disease show enhanced chemotaxis and extracellular proteolysis. Burnett, D., Chamba, A., Hill, S.L., Stockley, R.A. Lancet (1987) [Pubmed]
  8. Indium-111-labelled granulocyte accumulation in respiratory tract of patients with bronchiectasis. Currie, D.C., Saverymuttu, S.H., Peters, A.M., Needham, S.G., George, P., Dhillon, D.P., Lavender, J.P., Cole, P.J. Lancet (1987) [Pubmed]
  9. CFTR gene variant IVS8-5T in disseminated bronchiectasis. Pignatti, P.F., Bombieri, C., Benetazzo, M., Casartelli, A., Trabetti, E., Gilè, L.S., Martinati, L.C., Boner, A.L., Luisetti, M. Am. J. Hum. Genet. (1996) [Pubmed]
  10. Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchiectasis. Daviskas, E., Anderson, S.D., Eberl, S., Chan, H.K., Bautovich, G. Am. J. Respir. Crit. Care Med. (1999) [Pubmed]
  11. Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis. Tsang, K.W., Ho, P.L., Lam, W.K., Ip, M.S., Chan, K.N., Ho, C.S., Ooi, C.C., Yuen, K.Y. Am. J. Respir. Crit. Care Med. (1998) [Pubmed]
  12. Short term response of patients with bronchiectasis to treatment with amoxycillin given in standard or high doses orally or by inhalation. Hill, S.L., Morrison, H.M., Burnett, D., Stockley, R.A. Thorax (1986) [Pubmed]
  13. Genetic characterization of fluoroquinolone-resistant Streptococcus pneumoniae strains isolated during ciprofloxacin therapy from a patient with bronchiectasis. de la Campa, A.G., Ferrandiz, M.J., Tubau, F., Pallarés, R., Manresa, F., Liñares, J. Antimicrob. Agents Chemother. (2003) [Pubmed]
  14. pH in expired breath condensate of patients with inflammatory airway diseases. Kostikas, K., Papatheodorou, G., Ganas, K., Psathakis, K., Panagou, P., Loukides, S. Am. J. Respir. Crit. Care Med. (2002) [Pubmed]
  15. Lung mucociliary clearance. Mortensen, J., Lange, P., Nyboe, J., Groth, S. European journal of nuclear medicine. (1994) [Pubmed]
  16. Presence, activities, and molecular forms of cathepsin G, elastase, alpha 1-antitrypsin, and alpha 1-antichymotrypsin in bronchiectasis. Sepper, R., Konttinen, Y.T., Ingman, T., Sorsa, T. J. Clin. Immunol. (1995) [Pubmed]
  17. Neutrophil glutamine deficiency in relation to genotype in children with cystic fibrosis. D'Eufemia, P., Finocchiaro, R., Celli, M., Tote, J., Ferrucci, V., Zambrano, A., Troiani, P., Quattrucci, S. Pediatr. Res. (2006) [Pubmed]
  18. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Patel, I.S., Vlahos, I., Wilkinson, T.M., Lloyd-Owen, S.J., Donaldson, G.C., Wilks, M., Reznek, R.H., Wedzicha, J.A. Am. J. Respir. Crit. Care Med. (2004) [Pubmed]
  19. Neutrophil adhesion molecule surface expression and responsiveness in cystic fibrosis. Russell, K.J., McRedmond, J., Mukherji, N., Costello, C., Keatings, V., Linnane, S., Henry, M., Fitzgerald, M.X., O'Connor, C.M. Am. J. Respir. Crit. Care Med. (1998) [Pubmed]
  20. Evidence for eosinophil activation in bronchiectasis unrelated to cystic fibrosis and bronchopulmonary aspergillosis: discrepancy between blood eosinophil counts and serum eosinophil cationic protein levels. Kroegel, C., Schüler, M., Förster, M., Braun, R., Grahmann, P.R. Thorax (1998) [Pubmed]
  21. Inflammation: imaging with Tc-99m HMPAO-labeled leukocytes. Roddie, M.E., Peters, A.M., Danpure, H.J., Osman, S., Henderson, B.L., Lavender, J.P., Carroll, M.J., Neirinckx, R.D., Kelly, J.D. Radiology. (1988) [Pubmed]
  22. Systemic deficiency of glutathione in cystic fibrosis. Roum, J.H., Buhl, R., McElvaney, N.G., Borok, Z., Crystal, R.G. J. Appl. Physiol. (1993) [Pubmed]
  23. HLA-C and killer cell immunoglobulin-like receptor genes in idiopathic bronchiectasis. Boyton, R.J., Smith, J., Ward, R., Jones, M., Ozerovitch, L., Wilson, R., Rose, M., Trowsdale, J., Altmann, D.M. Am. J. Respir. Crit. Care Med. (2006) [Pubmed]
  24. Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections. Maciá, M.D., Blanquer, D., Togores, B., Sauleda, J., Pérez, J.L., Oliver, A. Antimicrob. Agents Chemother. (2005) [Pubmed]
  25. Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD. Gompertz, S., Bayley, D.L., Hill, S.L., Stockley, R.A. Thorax (2001) [Pubmed]
  26. Increased frequency of cystic fibrosis deltaF508 mutation in bronchiectasis associated with rheumatoid arthritis. Puéchal, X., Fajac, I., Bienvenu, T., Desmazes-Dufeu, N., Hubert, D., Kaplan, J.C., Menkès, C.J., Dusser, D.J. Eur. Respir. J. (1999) [Pubmed]
  27. Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis. de Jong, P.A., Lindblad, A., Rubin, L., Hop, W.C., de Jongste, J.C., Brink, M., Tiddens, H.A. Thorax (2006) [Pubmed]
  28. Gelatinolytic and type IV collagenolytic activity in bronchiectasis. Sepper, R., Konttinen, Y.T., Sorsa, T., Koski, H. Chest (1994) [Pubmed]
  29. Respiratory epithelial ion transport in patients with disseminated bronchiectasis. Danner, I., Boisseau, P., Chailleux, E., Escande, D. Eur. Respir. J. (1999) [Pubmed]
  30. Effect of azithromycin on bronchiectasis and pulmonary function in a heart-lung transplant patient with severe chronic allograft dysfunction: a case report. Verleden, G.M., Dupont, L.J., Vanhaecke, J., Daenen, W., Van Raemdonck, D.E. J. Heart Lung Transplant. (2005) [Pubmed]
  31. A comparative study on the efficacy of levofloxacin and ceftazidime in acute exacerbation of bronchiectasis. Tsang, K.W., Chan, W.M., Ho, P.L., Chan, K., Lam, W.K., Ip, M.S. Eur. Respir. J. (1999) [Pubmed]
WikiGenes - Universities